oral antipsychotic

0 marketed 1 in Phase 3

This page covers all oral antipsychotic drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Dopamine receptor.

Targets

Dopamine receptor

Phase 3 pipeline (1)

Patent intelligence